Biotechnology applied to health

Imagen Biotecnología aplicada a la salud

This programme is aimed at developing tools for diagnosis, prognosis and advanced or targeted therapies in personalised medicine. In particular, the parties express their willingness to identify, where applicable, as areas of future collaboration for the development of the programme the following lines of action (LA):

  • LA-1: BREM platform for cryo-electron microscopy applied to personalised medicine.
  • LA-2: Implementation and analysis of databases in precision medicine.
  • LA-3: Platform for drug screening and drug-target interaction analysis. LA-4: Development of biological models for screening and studying the activity of therapeutic molecules.
  • LA-5: Development of nanopharmaceuticals, biodistribution, toxicity and therapeutic actions in pathology models.
  • LA-6: Techniques and processes for advanced and targeted therapies, surgical training and medical robotics.

The programme was initially launched with the Autonomous Communities of Catalonia, Castile-La Mancha, Extremadura, the Basque Country and Galicia by signing a framework agreement with the Ministry of Science, Innovation and Universities. Subsequently, the Autonomous Communities of Galicia, Andalusia and Aragon joined following the Agreement of the Council for Scientific, Technological and Innovation Policy of 22 June 2022.

Plan Complementario en Biotecnología Aplicada a la Salud

icono-contacto

Secretaría General de Investigación

P.º de la Castellana 162. 28046 Madrid

planescomplementarios@ciencia.gob.es

Select the type of error you wish to report

  • If you have noticed that one of the links does not take you to a page...

  • If you have detected an URL error in a link...

  • If you have detected a content error...

  • If you have detected content that does not display...

  • If the information has not been useful...